Dr. Sudeep Soni explores the evolving role of dual–contrast agent liver MRI for improved characterization of focal liver lesions when single-agent protocols are limited. The episode breaks down how sequential use of extracellular and hepatobiliary contrast agents enhances diagnostic confidence, reduces uncertainty, and supports more informed patient care decisions.

Dual–Contrast Agent Liver MRI for Liver Lesion Characterization. Shetty et al. RadioGraphics 2026; 46(1):e250113.